Top of this page
Skip navigation, go straight to the content

ucb-usa.com Responsibility Transparency
 

Transparency

 

UCB’s interactions with healthcare professionals are a vital component of ensuring that UCB delivers innovative medicines to patients. These interactions, consistent with the PhRMA Code on Interactions with Healthcare Professionals, take on many forms, including clinical trial participation, consulting and advisory services, and on-going informational exchanges. 

 

Since August 1, 2013, U.S. federal law has required pharmaceutical, biological, and medical device companies to track and report such interactions to the Centers for Medicare and Medicaid Services (CMS).  The first Open Payments disclosure report was publicly posted September 30, 2014, on the CMS website. You can view the posted information on the Open Payments website and obtain additional information here: http://www.cms.gov/openpayments/index.html.

 

UCB is committed to complying with all federal and state transparency and disclosure requirements and submits annual reports on its interactions with health care professionals and organizations.  As new industry and government standards emerge, UCB will continue to ensure that our policies are in alignment.

 

To search UCB, Inc. Physician Payment Reports, visit the Open Payments website